Sputum cytokines associated with raised FeNO after anti‐IL5 biologic therapy in severe asthma-Reference-Cited by-同舟云学术

Sputum cytokines associated with raised FeNO after anti‐IL5 biologic therapy in severe asthma

Published:2024-01-10 Issue:8 Volume:79 Page:2244-2247
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Hekking Pieter‐Paul¹²^ORCID,Zhang Kayla¹,Garrido Carmen Paz Venegas¹,Lopez‐Rodriguez Raquel¹³,Kjarsgaard Melanie¹,Mukherjee Manali¹^ORCID,Nair Parameswaran¹^ORCID

Affiliation:

1. Division of Respirology, Department of Medicine, St. Joseph's Healthcare Hamilton McMaster University Hamilton Ontario Canada

2. Department of Respiratory Diseases, STZ Centre of Excellence for Asthma & COPD Franciscus Gasthuis & Vlietland Hospital Rotterdam The Netherlands

3. Department of Allergy Lucus Augusti Hospital Lugo Spain

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16011

Reference7 articles.

1. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma

2. Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena

3. Long‐term immune response accompanies clinical outcomes in severe asthmatics treated with anti‐IL‐5/IL‐5R biologics

4. The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

5. Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eosinophil-mucus interplay in severe asthma: Implications for treatment with biologicals;Allergology International;2024-07